Total Payments
$15,303
2024 Payments
$2,288
Companies
49
Transactions
848
Medicare Patients
6,594
Medicare Billing
$459,720
Payment Breakdown by Category
Food & Beverage$15,236 (99.6%)
Education$66.79 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,236 | 839 | 99.6% |
| Education | $66.79 | 9 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,979 | 62 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,590 | 121 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $1,564 | 90 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,534 | 94 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,291 | 83 | $0 (2024) |
| PFIZER INC. | $883.11 | 65 | $0 (2024) |
| Amgen Inc. | $758.17 | 51 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $728.97 | 40 | $0 (2024) |
| Esperion Therapeutics, Inc. | $609.19 | 24 | $0 (2024) |
| Merck Sharp & Dohme LLC | $542.89 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,288 | 111 | Boehringer Ingelheim Pharmaceuticals, Inc. ($352.51) |
| 2023 | $2,359 | 109 | Boehringer Ingelheim Pharmaceuticals, Inc. ($529.26) |
| 2022 | $1,636 | 89 | Boehringer Ingelheim Pharmaceuticals, Inc. ($335.74) |
| 2021 | $1,734 | 94 | Boehringer Ingelheim Pharmaceuticals, Inc. ($268.43) |
| 2020 | $1,766 | 108 | Janssen Pharmaceuticals, Inc ($315.92) |
| 2019 | $1,863 | 114 | Janssen Pharmaceuticals, Inc ($258.19) |
| 2018 | $1,814 | 105 | Janssen Pharmaceuticals, Inc ($376.70) |
| 2017 | $1,843 | 118 | Novartis Pharmaceuticals Corporation ($301.95) |
All Payment Transactions
848 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $2.51 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/17/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/10/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/09/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.07 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $101.43 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 12/02/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/26/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $7.45 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/18/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/15/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Cardiology | ||||||
| 11/05/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.07 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/04/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $21.77 | General |
| Category: Cardiology | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/18/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/11/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $22.38 | General |
| Category: Cardiology | ||||||
| 10/09/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/08/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $32.65 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,570 | 2,252 | $474,966 | $105,813 |
| 2022 | 11 | 1,518 | 2,190 | $476,595 | $106,130 |
| 2021 | 10 | 1,697 | 2,347 | $549,497 | $125,922 |
| 2020 | 13 | 1,809 | 2,427 | $549,179 | $121,856 |
Total Patients
6,594
Total Services
9,216
Medicare Billing
$459,720
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 432 | 757 | $221,801 | $64,299 | 29.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 122 | 123 | $98,769 | $17,041 | 17.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 607 | 941 | $80,926 | $9,147 | 11.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 65 | 66 | $29,634 | $2,966 | 10.0% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 17 | 17 | $13,600 | $2,772 | 20.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $6,822 | $1,981 | 29.0% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 57 | 64 | $4,224 | $1,933 | 45.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 19 | $3,914 | $955.16 | 24.4% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 49 | 51 | $4,437 | $942.82 | 21.2% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 25 | 29 | $2,581 | $932.51 | 36.1% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 39 | 41 | $2,327 | $728.80 | 31.3% |
| 93291 | Evaluation of cardiac rhythm monitor system | Office | 2023 | 30 | 33 | $1,584 | $721.80 | 45.6% |
| 93281 | Programming of multiple lead pacemaker system | Office | 2023 | 16 | 16 | $1,216 | $525.60 | 43.2% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 19 | 19 | $1,159 | $361.44 | 31.2% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 37 | 39 | $1,326 | $346.48 | 26.1% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 19 | 19 | $646.00 | $159.74 | 24.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 475 | 783 | $229,419 | $67,422 | 29.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 139 | 141 | $113,223 | $19,505 | 17.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 641 | 995 | $85,570 | $9,793 | 11.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 55 | 57 | $25,593 | $2,676 | 10.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $7,580 | $2,201 | 29.0% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2022 | 65 | 68 | $5,916 | $1,187 | 20.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 17 | $3,502 | $1,126 | 32.1% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2022 | 38 | 39 | $2,184 | $708.99 | 32.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2022 | 19 | 20 | $1,320 | $674.20 | 51.1% |
About Dr. Herbert Strunk, DO
Dr. Herbert Strunk, DO is a Cardiovascular Disease healthcare provider based in Pinehurst, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861448649.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Herbert Strunk, DO has received a total of $15,303 in payments from pharmaceutical and medical device companies, with $2,288 received in 2024. These payments were reported across 848 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($15,236).
As a Medicare-enrolled provider, Strunk has provided services to 6,594 Medicare beneficiaries, totaling 9,216 services with total Medicare billing of $459,720. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Pinehurst, NC
- Active Since 05/25/2006
- Last Updated 06/05/2019
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1861448649
Products in Payments
- JARDIANCE (Drug) $1,702
- LifeVest (Device) $1,564
- XARELTO (Drug) $1,534
- ELIQUIS (Drug) $1,431
- ENTRESTO (Drug) $1,393
- BRILINTA (Drug) $811.14
- VERQUVO (Drug) $542.89
- Corlanor (Drug) $432.22
- FARXIGA (Drug) $413.72
- WATCHMAN FLX (Device) $390.49
- NEXLETOL (Drug) $351.00
- FUROSCIX (Drug) $337.80
- Repatha (Biological) $325.95
- MULTAQ (Drug) $290.81
- PRADAXA (Drug) $277.67
- NORTHERA (Drug) $259.68
- NEXLIZET (Drug) $258.19
- LEQVIO (Drug) $196.83
- ZIO XT Patch (Device) $169.01
- Kerendia (Drug) $168.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Pinehurst
Patrick Simpson, Md, MD
Cardiovascular Disease — Payments: $816,276
Cardiovascular Disease $816,276
Keith Davis, Md, MD
Cardiovascular Disease — Payments: $11,216
Cardiovascular Disease $11,216
Peter Vassallo, M.d, M.D
Cardiovascular Disease — Payments: $10,610
Cardiovascular Disease $10,610
Ker Boyce, Md, MD
Cardiovascular Disease — Payments: $10,577
Cardiovascular Disease $10,577
David Cowherd, Md, MD
Cardiovascular Disease — Payments: $7,578
Cardiovascular Disease $7,578
Joseph Parrish, Md, MD
Cardiovascular Disease — Payments: $3,421
Cardiovascular Disease $3,421